JUUL

Organization
Mentions
4
Relationships
0
Events
0
Documents
2

Relationship Network

Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons. Drag nodes to reposition. Node size indicates connection count. Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak). Use legend and help buttons in the graph for more guidance.
No relationships found for this entity.
No events found for this entity.

HOUSE_OVERSIGHT_024867.jpg

A Cowen 'Collaborative Insights' financial report page dated February 25, 2019, analyzing the U.S. market for CBD vapor and e-cigarettes. The document projects significant growth in the sector, forecasting CBD vape revenues to reach $360 million by 2020 and comparing this to JUUL's market share. The page includes three figures (95, 96, 97) illustrating sales forecasts and scenario analysis, and bears a House Oversight Committee Bates stamp.

Financial research report / market analysis
2025-11-19

HOUSE_OVERSIGHT_024824.jpg

This document is page 8 of a Cowen market research report dated February 25, 2019, analyzing the market size and consumer demographics of CBD products. It details survey results from January 2019 showing a 6.9% usage rate, skewing towards younger demographics (18-34), and identifies tinctures as the dominant delivery mechanism. While the document bears a 'HOUSE_OVERSIGHT' Bates stamp (often associated with financial probes into banks connected to Jeffrey Epstein), the content of this specific page is strictly financial market analysis regarding CBD and tobacco/vaping products.

Financial market research report
2025-11-19
Total Received
$0.00
0 transactions
Total Paid
$0.00
0 transactions
Net Flow
$0.00
0 total transactions
No financial transactions found for this entity. Entity linking may need to be improved.
As Sender
0
As Recipient
0
Total
0
No communications found for this entity. Entity linking may need to be improved.

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein entity